Diastolic dysfunction: A link between hypertension and heart failure

Drugs of Today

Volumn 44, Issue 7, 2008, Pages 503-513

  Lalande, Sophie ^a   Johnson, Bruce D ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 2 RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRAIN NATRIURETIC PEPTIDE; CALCIUM CHANNEL BLOCKING AGENT; CANDESARTAN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

BLOOD PRESSURE REGULATION; DIASTOLIC DYSFUNCTION; DOPPLER ECHOCARDIOGRAPHY; DYSPNEA; EXERCISE; HEART ATRIUM CONTRACTION; HEART FAILURE; HEART LEFT VENTRICLE FILLING; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; HYPERTENSION; NUCLEAR MAGNETIC RESONANCE IMAGING; REVIEW; TACHYCARDIA;

ADRENERGIC BETA-ANTAGONISTS; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; DIASTOLE; HEART FAILURE; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; VENTRICULAR DYSFUNCTION, LEFT;

EID: 51349134172     PISSN: 16993993     EISSN: 16994019     Source Type: Journal    
DOI: 10.1358/dot.2008.44.7.1221662     Document Type: Review

References (77)

1. Hunt, S.A., Abraham, W.T., Chin, M.H. et al. ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): Developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: Endorsed by the Heart Rhythm Society. Circulation 2005, 112(12): e154-235.
2. American Heart Association. Heart disease and stroke statistics: 2005 update. 2005, American Heart Association: Dallas, Texas.
3. Thorn, T., Haase, N., Rosamond, W. et al. Heart diseases and stroke statistics-2006 update: A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2006, 113(6): e85-151.
4. Levy, D., Larson, M.G., Vasan, R.S., Kannel, W.B., Ho, K.K. The progression from hypertension to congestive heart failure. JAMA 1996, 275(20): 1557-62.
5. Setaro, J.F., Zaret, B.L., Schulman, D.S., Black, H.R., Soufer, R. Usefulness of verapamil for congestive heart failure associated with abnormal left ventricular diastolic filling and normal left ventricular systolic performance. Am J Cardiol 1990, 66(12): 981-6.
6. Lloyd-Jones, D.M., Larson, M.G., Leip, E.P. et al. Lifetime risk for developing congestive heart failure: the Framingham Heart Study. Circulation 2002, 106(24): 3068-72.
7. Zile, M.R., Brutsaert, D.L. New concepts in diastolic dysfunction and diastolic heart failure: Part I: Diagnosis, prognosis, and measurements of diastolic function. Circulation 2002, 105(11): 1387-93.
8. Senni, M., Tribouilloy, C.M., Rodeheffer, R.J., Jacobsen, S.J., Evans, J.M., Bailey, K.R., Redfield, M.M. Congestive heart failure in the community: A study of all incident cases in Olmsted County, Minnesota, in 1991. Circulation 1998, 98(21): 2282-9.
9. Vasan, R.S., Levy, D. Defining diastolic heart failure: A call for standardized diagnostic criteria. Circulation 2000, 101(17): 2118-21.
10. Regitz-Zagrosek, V., Brokat, S., Tschope, C. Role of gender in heart failure with normal left ventricular ejection fraction. Prog Cardiovasc Dis 2007, 49(4): 241-51.
11. Kitzman, D.W., Higginbotham, M.B., Cobb, F.R., Sheikh, K.H., Sullivan, M.J. Exercise intolerance in patients with heart failure and preserved left ventricular systolic function: Failure of the Frank-Starling mechanism. J Am Coll Cardiol 1991, 17(5): 1065-72.
12. Gutierrez, C., Blanchard, D.G. Diastolic heart failure: Challenges of diagnosis and treatment. Am Fam Physician 2004, 69(11): 2609-16.
13. Spencer, K.T., Lang, R.M. Diastolic heart failure. What primary care physicians need to know. Postgrad Med 1997, 101(1): 63-5, 68, 71-3 passim.
14. Zile, M.R., Brutsaert, D.L. New concepts in diastolic dysfunction and diastolic heart failure: Part II: Causal mechanisms and treatment. Circulation 2002, 105(12): 1503-8.
15. Bursi, F., Weston, S.A., Redfield, M.M. et al. Systolic and diastolic heart failure in the community. JAMA 2006, 296(18): 2209-16.
16. Redfield, M.M. Heart failure-an epidemic of uncertain proportions. N Engl J Med 2002, 347(18): 1442-4.
17. Judge, K.W., Pawitan, Y., Caldwell, J., Gersh, B.J., Kennedy, J.W. Congestive heart failure symptoms in patients with preserved left ventricular systolic function: Analysis of the CASS registry. J Am Coll Cardiol 1991, 18(2): 377-82.
18. Ruskoaho, H. Atrial natriuretic peptide: Synthesis, release, and metabolism. Pharmacol Rev 1992, 44(4): 479-602.
19. Nousiainen, T., Vanninen, E., Jantunen, E. et al. Natriuretic peptides during the development of doxorubicin-induced left ventricular diastolic dysfunction. J Intern Med 2002, 251 (3): 228-34.
20. Nagueh, S.F., Middleton, K.J., Kopelen, H.A., Zoghbi, W.A., Quinones, M.A. Doppler tissue imaging: A noninvasive technique for evaluation of left ventricular relaxation and estimation of filling pressures. J Am Coll Cardiol 1997, 30(6): 1527-33.
21. Sohn, D.W., Chai, I.H., Lee, D.J. et al. Assessment of mitral annulus velocity by Doppler tissue imaging in the evaluation of left ventricular diastolic function. J Am Coll Cardiol 1997, 30(2): 474-80.
22. Little, W.C., Downes, T.R. Clinical evaluation of left ventricular diastolic performance. Prog Cardiovasc Dis 1990, 32(4): 273-90.
23. Cosson, S., Kevorkian, J.P. Left ventricular diastolic dysfunction: An early sign of diabetic cardiomyopathy? Diabetes Metab 2003, 29(5): 455-66.
24. Fang, Z.Y., Prins, J.B., Marwick, T.H. Diabetic cardiomyopathy: Evidence, mechanisms, and therapeutic implications. Endocr Rev 2004, 25(4): 543-67.
25. Choong, C.Y., Abascal, V.M., Thomas, J.D., Guerrero, J.L., McGlew, S., Weyman, A.E. Combined influence of ventricular loading and relaxation on the transmitral flow velocity profile in dogs measured by Doppler echocardiography. Circulation 1988, 78(3): 672-83.
26. Regan, T.J., Lyons, M.M., Ahmed, S.S., Levinson, G.E., Oldewurtel, H.A., Ahmad, M.R., Haider, B. Evidence for cardiomyopathy in familial diabetes mellitus. J Clin Invest 1977, 60(4): 884-99.
27. Astorri, E., Fiorina, P., Contini, G.A., Albertini, D., Magnati, G., Astorri, A., Lanfredini, M. Isolated and preclinical impairment of left ventricular filling in insulin-dependent and non-insulin-dependent diabetic patients. Clin Cardiol 1997, 20(6): 536-40.
28. Bouchard, A., Sanz, N., Botvinick, E.H. et al. Noninvasive assessment of cardiomyopathy in normotensive diabetic patients between 20 and 50 years old. Am J Med 1989, 87(2): 160-6.
29. 2 difference in type 2 diabetes. J Appl Physiol 2003, 94(3): 1033-8.
30. Douglas, P.S., O'Toole, M. Aging and physical activity determine cardiac structure and function in the older athlete. J Appl Physiol 1992, 72(5): 1969-73.
31. Fleg, J.L., Shapiro, E.P., O'Connor, F., Taube, J., Goldberg, A.P., Lakatta, E.G. Left ventricular diastolic filling performance in older male athletes. JAMA 1995, 273(17): 1371-5.
32. Arbab-Zadeh, A., Dijk, E., Prasad, A. et al. Effect of aging and physical activity on left ventricular compliance. Circulation 2004, 110(13): 1799-805.
33. Shapiro, L.M. Echocardiography features of impaired ventricular function in diabetes mellitus. Br Heart J 1982, 47(5): 439-44.
34. Shehadeh, A., Regan, T.J. Cardiac consequences of diabetes mellitus. Clin Cardiol 1995, 18(6): 301-5.
35. Celentano, A., Vaccaro, O., Tammaro, P. et al. Early abnormalities of cardiac function in non-insulin-dependent diabetes mellitus and impaired glucose tolerance. Am J Cardiol 1995, 76(16): 1173-6.
36. Poirier, P., Bogaty, P., Garneau, C., Marois, L., Dumesnil, J.G. Diastolic dysfunction in normotensive men with well-controlled type 2 diabetes: Importance of maneuvers in echocardiographic screening for preclinical diabetic cardiomyopathy. Diabetes Care 2001, 24(1): 5-10.
37. Inoue, T., Fujito, T., Asahi, S., Hoshi, K., Sakai, Y., Morooka, S. Impaired left ventricular dias tolic filling occurs in diabetic patients without atherosclerotic coronary artery disease. Am J Med Sci 1997, 313(3): 125-30.
38. Zarich, S.W., Arbuckle, B.E., Cohen, L.R., Roberts, M., Nesto, R.W. Diastolic abnormalities in young asymptomatic diabetic patients assessed by pulsed Doppler echocardiography. J Am Coll Cardiol 1988, 12(1): 114-20.
39. Kitzman, D.W., Sheikh, K.H., Beere, P.A., Philips, J.L., Higginbotham, M.B. Age-related alterations of Doppler left ventricular filling indexes in normal subjects are independent of left ventricular mass, heart rate, contractility and loading conditions. J Am Coll Cardiol 1991, 18(5): 1243-50.
40. Pela, G., Regolisti, G., Coghi, P. et al. Effects of the reduction of preload on left and right ventricular myocardial velocities analyzed by Doppler tissue echocardiography in healthy subjects. Eur J Echocardiogr 2004, 5(4): 262-71.
41. Hammermeister, K.E., Warbasse, J.R. The rate of change of left ventricular volume in man. II. Diastolic events in health and disease. Circulation 1974, 49(4): 739-47.
42. Sandstede, J., Lipke, C., Beer, M. et al. Age-and gender-specific differences in left and right ventricular cardiac function and mass determined by cine magnetic resonance imaging. Eur Radiol 2000, 10(3): 438-42.
43. Alfakih, K., Reid, S., Jones, T., Sivananthan, M. Assessment of ventricular function and mass by cardiac magnetic resonance imaging. Eur Radiol 2004, 14(10): 1813-22.
44. Young, A.A., Cowan, B.R., Thrupp, S.F., Hedley, W.J., Dell'Italia, L.J. Left ventricular mass and volume: Fast calculation with guidepoint modeling on MR images. Radiology 2000, 216(2): 597-602.
45. Grossman, W., Jones, D., McLaurin, L.P. Wall stress and patterns of hypertrophy in the human left ventricle. J Clin Invest 1975, 56(1): 56-64.
46. Weber, K.T. Cardiac interstitium in health and disease: The fibrillar collagen network. J Am Coll Cardiol 1989, 13(7): 1637-52.
47. Berk, B.C., Fujiwara, K., Lehoux, S. ECM remodeling in hypertensive heart disease. J Clin Invest 2007, 117(3): 568-75.
48. Berenji, K., Drazner, M.H., Rothermel, B.A., Hill, J.A. Does load-induced ventricular hypertrophy progress to systolic heart failure? Am J Physiol Heart Circ Physiol 2005, 289(1): H8-H16.
49. Dostal, D.E., Baker, K.M. Angiotensin II stimulation of left ventricular hypertrophy in adult rat heart. Mediation by the AT1 receptor. Am J Hypertens 1992, 5(5, Pt. 1): 276-80.
50. Schut, A.F., Bleumink, G.S., Stricker, B.H. et al. Angiotensin converting enzyme insertion/deletion polymorphism and the risk of heart failure in hypertensive subjects. Eur Heart J 2004, 25(23): 2143-8.
51. Studer, R., Reinecke, H., Muller, B., Holtz, J., Just, H., Drexler, H. Increased angiotensin-I converting enzyme gene expression in the failing human heart. Quantification by competitive RNA polymerase chain reaction. J Clin Invest 1994, 94(1): 301-10.
52. Rigat, B., Hubert, C., Alhenc-Gelas, F., Cambien, F., Corvol, P., Soubrier, F. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 1990, 86(4): 1343-6.
53. Tiret, L., Rigat, B., Visvikis, S., Breda, C., Corvol, P., Cambien, F., Soubrier, F. Evidence, from combined segregation and linkage analysis, that a variant of the angiotensin I-converting enzyme (ACE) gene controls plasma ACE levels. Am J Hum Genet 1992, 51(1): 197-205.
54. Brutsaert, D.L., Housmans, P.R., Goethals, M.A. Dual control of relaxation. Its role in the ventricular function in the mammalian heart. Circ Res 1980, 47(5): 637-52.
55. Weber, K.T., Janicki, J.S., Hunter, W.C., Shroff, S., Pearlman, E.S., Fishman, A.P. The contractile behavior of the heart and its functional coupling to the circulation. Prog Cardiovasc Dis 1982, 24(5): 375-400.
56. Arai, M., Matsui, H., Periasamy, M. Sarcoplasmic reticulum gene expression in cardiac hypertrophy and heart failure. Circ Res 1994, 74(4): 555-64.
57. Yusuf, S., Pfeffer, M.A., Swedberg, K. et al.; CHARM Investigators and Committees. Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: The CHARM-Preserved Trial. Lancet 2003, 362(9386): 777-81.
58. Kostis, J.B., Davis, B.R., Cutler, J. et al. Prevention of heart failure by antihypertensive drug treatment in older persons with isolated systolic hypertension. SHEP Cooperative Research Group. JAMA 1997, 278(3): 212-6.
59. Moser, M., Hebert, P.R. Prevention of disease progression, left ventricular hypertrophy and congestive heart failure in hypertension treatment trials. J Am Coll Cardiol 1996, 27(5): 1214-8.
60. Gillebert, T.C., Leite-Moreira, A.F., De Hert, S.G. Load dependent diastolic dysfunction in heart failure. Heart Fail Rev 2000, 5(4): 345-55.
61. Angomachalelis, N., Hourzamanis, A.I., Sideri, S., Serasli, E., Vamvalis, C. Improvement of left ventricular diastolic dysfunction in hypertensive patients 1 month after ACE inhibition therapy: Evaluation by ultrasonic automated boundary detection. Heart Vessels 1996, 11(6): 303-9.
62. Mitsunami, K., Inoue, S., Maeda, K. et al. Three-month effects of candesartan cilexetil, an angiotensin II type 1 (AT1) receptor antagonist, on left ventricular mass and hemodynamics in patients with essential hypertension. Cardiovasc Drugs Ther 1998, 12(5): 469-74.
63. Brilla, C.G., Funck, R.C., Rupp, H. Lisinopril-mediated regression of myocardial fibrosis in patients with hypertensive heart disease. Circulation 2000, 102(12): 1388-93.
64. Chen, H., Lainchbury, J.B., Senni, M., Redfield, M.M. Factors influencing survival in patients with diastolic heart failure in Olmsted County, Minn. Circulation 2000, 102: 11412.
65. Watanabe, K., Juan, W., Narasimman, G. et al. Betaxolol improves the survival rate and changes natriuretic peptide expression in rats with heart failure. J Cardiovasc Pharmacol 2003, 41 (Suppl. 1): S99-103.
66. Satpathy, C., Mishra, T.K., Satpathy, R., Satpathy, H.K., Barone, E. Diagnosis and management of diastolic dysfunction and heart failure. Am Fam Physician 2006, 73(5): 841-6.
67. Zile, M., Gaasch, W., Little, W., Francis, G., Tavazzi, L., Cleland, J., Davies, M.; MCC-135 GO1 Investigators. A phase II, double-blind, randomized, placebo-controlled, dose comparative study of the efficacy, tolerability, and safety of MCC-135 in subjects with chronic heart failure, NYHA class II/III (MCC-135-GO1 study): Rationale and design. J Card Fail 2004, 10(3): 193-9.
68. del Monte, F., Harding, S.E., Schmidt, U. et al. Restoration of contractile function in isolated cardiomyocytes from failing human hearts by gene transfer of SERCA2a. Circulation 1999, 100(23): 2308-11.
69. Little, W.C., Kitzman, D.W., Cheng, C.P. Diastolic dysfunction as a cause of exercise intolerance. Heart Fail Rev 2000, 5(4): 301-6.
70. Borlaug, B.A., Melenovsky, V., Russell, S.D., Kessler, K., Pacak, K., Becker, L.C., Kass, D.A. Impaired chronotropic and vasodilator reserves limit exercise capacity in patients with heart failure and a preserved ejection fraction. Circulation 2006, 114(20): 2138-47.
71. Warner, J.G. Jr., Metzger, D.C., Kitzman, D.W., Wesley, D.J., Little, W.C. Losartan improves exercise tolerance in patients with diastolic dysfunction and a hypertensive response to exercise. J Am Coll Cardiol 1999, 33(6): 1567-72.
72. Arruda, A.L., Pellikka, P.A., Olson, T.P., Johnson, B.D. Exercise capacity, breathing pattern, and gas exchange during exercise for patients with isolated diastolic dysfunction. J Am Soc Echocardiogr 2007, 20(7): 838-46.
73. Sin, D.D., Fitzgerald, F., Parker, J.D., Newton, G.E., Logan, A.G., Floras, J.S., Bradley, T.D. Relationship of systolic BP to obstructive sleep apnea in patients with heart failure. Chest 2003, 123(5): 1536-43.
74. Lanfranchi, P.A., Somers, V.K., Braghiroli, A., Corra, U., Eleuteri, E., Giannuzzi, P. Central sleep apnea in left ventricular dysfunction: Prevalence and implications for arrhythmic risk. Circulation 2003, 107(5): 727-32.
75. Kjaergaard, J., Snyder, E.M., Hassager, C., Olson, T.P., Oh, J.K., Johnson, B.D. The effect of 18 h of simulated high altitude on left ventricular function. Eur J Appl Physiol 2006, 98(4): 411-8.
76. Chen, L., Shi, Q., Scharf, S.M. Hemodynamic effects of periodic obstructive apneas in sedated pigs with congestive heart failure. J Appl Physiol 2000, 88(3): 1051-60.
77. Young, T., Peppard, P., Palta, M., Hla, K.M., Finn, L., Morgan, B., Skatrud, J. Population-based study of sleep-disordered breathing as a risk factor for hypertension. Arch Intern Med 1997, 157(15): 1746-52.